Krilogy Financial LLC Incyte Corp Transaction History

Krilogy Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $17,550 - $20,982	-300 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $18,525 - $22,269	300 New	300 $21,000
Q2 2018 Aug 15, 2018	SELL	$60.85 - $83.98 $37,118 - $51,227	-610 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $8,306 - $10,098	-100 Reduced 14.08%	610 $51,000
Q2 2017 Aug 15, 2017	BUY	N/A	710	710 $89,000

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.